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There was a 100% response rate in the second survey. Respondents worked at
chain-based outpatient facilities in the USA, and all had used the algorithm for
6 months on 2–4 patients. Sixty-four percent of respondents felt the algorithm
improved or signiﬁcantly improved their patient interactions, the remainder
saw no change, and 57% thought the algorithm increased their understanding
of the patient’s condition. Algorithm use increased the mean estimated
monthly nutrition care time per patient compared to average habits
(po0.001); 45727minutes without the algorithm,100743minutes in month
1 of the algorithm, and 77735 minutes in the last month. The additional time
was distributed evenly between interaction and documentation.
These surveys show that dietitians felt that an online nutrition algorithm
may improve dietitian-patient interactions and understanding of patient
conditions which may be helpful in medically complex cases.
http://dx.doi.org/10.1016/j.krcp.2012.04.397
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MALNUTRITION INFLAMMATION SCORE IS COMPARABLE TO SUBJECTIVE
GLOBAL ASSESSMENT AS A NUTRITIONAL ASSESSMENT TOOL FOR
PERITONEAL DIALYSIS PATIENTS
Irene Haramis, Mary Anne Silvers, Karen Salamon, Julie Woods,
Catherine Huggins
Dietetics Department, Southern Health, Monash Medical Centre, VIC, Australia
Malnutrition is highly prevalent in dialysis patients. Appropriate
assessment tools are key for its prevention and treatment. This study aimed
to provide information regarding the Malnutrition Inﬂammation score
(MIS) as a nutritional assessment tool in Peritoneal Dialysis (PD) patients by
analysing relationships with other standard measures of nutritional status,
and comparing them with the Subjective Global Assessment (SGA). The
study also aimed to provide information regarding the nutritional status of
a cohort of Australian PD patients, which is lacking in current literature.
Ninety stable PD patients received a nutritional assessment over a period of
6 months. Nutritional status was assessed by MIS, SGA, serum albumin,
c-reactive protein (CRP), body mass index (BMI), mid arm muscle
circumference (MAMC), and a 24-hour recall to measure energy and protein
intake. Estimated glucose absorption from the dialysate was also included.
Correlations between MIS, SGA and the other measures of nutritional status
were analysed (using Spearman’s analysis, SPSS, v 17.0) and compared.
Thirty seven percent of the study group was considered to be malnourished
according to SGA score. The median MIS score was 5.0 (2.5–7.5). MIS and
SGA were both inversely correlated with energy intake (p¼0.002, p¼0.001
respectively), serum albumin (po0.001, po0.001 respectively), BMI
(p¼0.002, p¼0.006 respectively) and MAMC (p¼0.001, p¼0.008
respectively).In conclusion, the MIS was comparable to the SGA when
correlated with standard markers of nutritional assessment. The results
indicate that the MIS is a useful nutritional assessment tool for PD patients.
The study also showed that 37% of patients were malnourished, providing
information regarding the nutritional status of Australian PD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.398
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IMPAIRED GLUCOSE METABOLISM DESPITE DECREASED INSULIN
RESISTANCE AFTER RENAL TRANSPLANTATION
Manfred Hecking, Alexander Kainz, Johannes Werzowa, Michael Haidinger,
Andrea Tura, Angelo Karaboyas, Walter H. Horl, Michael Wolzt,
Giovanni Pacini, Friedrich K. Port, Marcus D. Semann
Medical University of Vienna/Austria, Institute of Biomedical Engineering
Padova/Italy, Arbor Research Collaborative for Health
The pathophysiology underlying new-onset diabetes after
transplantation (NODAT) is unresolved. We obtained demographics and
laboratory data from all 1064 renal transplant recipients followed at our
outpatient clinic in 2009/2010, randomly assigned 307 patients without
previously diagnosed diabetes to a routine 2-hour oral glucose tolerance
test (OGTT), and compared the metabolic results to a large, unrelated cross-
sectional cohort of non-transplanted subjects. Among renal transplant
recipients, 11% had a history of NODAT, and 12% had type 1 and type
2 diabetes. 42% of all OGTTs were abnormal (9% diabetic), predominantly in
older patients who received tacrolimus. Compared to non-transplanted
subjects, basal glucose was lower and HbA1c higher in renal transplant
patients. Compared to non-transplanted subjects, insulin secretion was
inferior, and insulin sensitivity improved at Z6 months, as well as
3 months post-transplantation:(The Figure shows linear spline
interpolation; all p for overall difference between non-Tx and Tx patients
o0.02, using likelihood ratio testing). Our results indicate that impaired
insulin secretion is the predominant problem after renal transplantation,
suggesting beneﬁt for therapeutic regimens that preserve beta cell function
after renal transplantation. The mechanism of increased insulin sensitivity
might be pathophysiologically similar to pancreatogenic diabetes.
http://dx.doi.org/10.1016/j.krcp.2012.04.399
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TRANSTHYRETIN PREDICTS CARDIOVASCULAR OUTCOME IN
HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS TYPE 2
Andrea Henze, Katharina Espe, Christoph Wanner, Vera Krane, Jens Raila,
Berthold Hocher, Florian J. Schweigert, Christiane Drechsler
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany
Department of Internal Medicine I, University of Wurzburg, Wurzburg,
Germany
BMI and albumin are commonly accepted parameters to recognize
wasting in dialysis patients and are powerful predictors of morbidity and
mortality. However, both parameters reveal limitations and may not cover
the entire range of patients with wasting. The visceral protein transthyretin
(TTR) may be helpful in overcoming the diagnostic and prognostic gap.
Therefore, the aim of this study was to assess the association of TTR with
morbidity and mortality in hemodialysis patients. The TTR concentration
was determined in baseline plasma samples of 1177 hemodialysis patients
with diabetes mellitus type 2. Cox regression analyses were used to
determine hazard ratios for the risk of cardiovascular events (CVE) and
mortality according to quartiles of TTR plasma concentration for the total
study cohort and the subgroups BMI Z23kg/m2, albumin concentration
Z3.8g/dL and a combination of both.
A low TTR concentration was associated with an increased risk for CVE
for the total study cohort (HR 1.65; 95% CI 1.27-2.14), patients with BMI
Z23kg/m2 (HR 1.70; 95% CI 1.22–2.37), albumin Z3.8g/dL (HR 1.68; 95%
CI 1.17–2.42) and the combination of both (HR 1.69; 95% CI 1.13-2.53).
Additionally, a low TTR concentration predicted all-cause mortality for the
total study cohort (HR 1.79; 95% CI 1.43–2.24) and patients with BMI
Z23kg/m2 (HR 1.46; 95% CI 1.09–1.95). In conclusion, the present study
demonstrated that TTR is a useful predictor for cardiovascular outcome and
mortality in hemodialysis patients. TTR was particularly useful in patients
who were not identiﬁed to be at risk by BMI or albumin status.
http://dx.doi.org/10.1016/j.krcp.2012.04.400
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AUDIT OF THE PREVALENCE OF MALNUTRITION USING THE MODIFIED
SUBJECTIVE GLOBAL ASSESSMENT TOOL IN MAINTENANCE PERITONEAL
DIALYSIS PATIENTS IN THE TOP END RENAL SERVICE OF THE NORTEHRN
TERRITORY AUSTRALIA
Greta Hollis
Royal Darwin Hospital, Darwin, Australia. Currently working at The Prince
Charles Hospital, Brisbane, Australia
Introduction: The objective of the audit is to determine the prevalence of
malnutrition in maintenance peritoneal dialysis (MPD) patients in the Top End
of the Northern Territory, using the modiﬁed Subjective Global Assessment
(SGA) tool. Methods: The audit was conducted in an outpatients setting.
Approximately 75% of PD patients in the Top End Renal service are represented
by Aboriginal and Torres Strait Island people. The study population was MPD
patients in the Top End Renal Service (TERS) of the Northern Territory, from
January 1st 2010 to December 31st 2010. Results were compared to
malnutrition rates found in the 2008/09 the audit of MPD patients in the TERS.
The SGA’s were performed by the renal Dietitian as part of the standard dietetic
support of MPD patients. SGA scores were collected from patient medical
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charts. Results: Patients were classiﬁed into one of three categories, based on
their SGA score (A) Well-nourished; (B) Mild- Moderate Malnutrition,
(C) Severe malnutrition. Malnutrition (B or C) was detected in 10% of PD
patients, compared to the 2008/09 audit where 76% of MPD patients had some
degree of malnutrition. Summary: These results were much lower than
malnutrition rates (76%) in the MPD patients audited in 2008/09. A number of
factors affecting the PD service after the 2008/09 audit could explain the
decrease in malnutrition rates including the implementation of free oral
nutrition supplements to MPD patients, development of service wide culturally
appropriate education resources used in the pre-dialysis and dialysis stage.
Future research into the correlation between improved peritonitis rates and
decreased malnutrition rates in the population are warranted.
http://dx.doi.org/10.1016/j.krcp.2012.04.401
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BODY MASS INDEX MODIFIED PREDICTIVE ABILITY OF BIOMARKERS
FOR PROTEIN-ENERGY WASTING IN PREVALENT
HEMODIALYSIS PATIENTS
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Protein-energy wasting (PEW) is crucial complication in prevalent
hemodialysis (HD) patients. Abnormality of biomarkers such as IL-6, NT-pro-
BNP, and adiponectin (ADPN) contribute to PEW. However, associations of the
biomarkers with PEW according to BMI levels have not been fully evaluated.
Thus those associations were assessed by a cross-sectional cohort study of
prevalent HD patients (n¼386). PEW was deﬁned by subjective global
assessment (n¼108). IL-6 levels were inversely, and NT-pro-BNP and ADPN
levels were positively correlated with BMI levels. Odds ratio (OR) of log IL-6 (OR
1.5, CI 1.0, 2.2), log NT-pro-BNP (OR 1.7, CI 1.3, 2.2), and log ADPN (OR 1.9, CI
1.1, 3.2) to PEW were signiﬁcantly increased in logistic multivariate regression
model. ORs of log NT-pro-BNP and log ADPN for PEW were progressively
increased in patients with threshold 21 kg/m2oBMI, but progressively
decreased in those below this threshold. On the other hand, OR of log IL-6 for
PEW was progressively decreased in patients with threshold 21 kg/m2oBMI,
but similar in those below this threshold. These associations were conﬁrmed by
the models adjusted with confounder. In conclusions, predictive values of IL-6,
NT-pro-BNP and ADPN for PEW state may be dependent on BMI levels in
prevalent HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.402
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ENCAPSULATING PERITONEAL SCLEROSIS: AN EXPERIENCE FROM A
SINGLE KOREAN UNIVERSITY CENTER
Kyung-Deuk Hong, Owen Kwon, Jang-Hee Cho, Chung-Hoon Yu, Ga-
Young Park, Jun-Seop Kim, Yoon-Jung Kang, Ji-Young Choi, Chan-Duck Kim,
Yong-Lim Kim, Sun-Hee Park
Kyungpook National University Hospital, Daegu, Republic of Korea
Clinical Research Center for End Stage Renal Disease in Korea
The aim of this study was to investigate the incidence and clinical
features of EPS in PD patients from a single university center in Korea. The
data were retrospectively collected from 606 prevalent PD patients
between August 2001 and August 2011. The diagnosis of EPS was based on
clinical signs and symptoms, mostly conﬁrmed by radiological ﬁndings.
Eight patients (incidence rate of 1.3%) were diagnosed with EPS. They
had at least one of three symptoms: abdominal pain, vomiting, or
abdominal distension. Mean age of the patients (4 males and 4 females)
was 48.5 (range: 33 to 65) years. Mean duration of PD was 111.8 (range: 23
to 186) months. The causes of ESRD were chronic glomerulonephritis
(n¼6), followed by hypertensive nephrosclerosis (n¼1) and diabetic
nephropathy (n¼1). All the patients except one had 3 or more episodes of
peritonitis. Seven patients were diagnosed with EPS after stopping PD and
only one stayed on PD after initial diagnosis and treatment. The use of
icodextrin or beta-blockers and angiotensin-converting enzyme inhibitors
or angiotensin II receptor blockers was not different in the patients without
EPS. Total parenteral nutrition was used in all patients. Three patients were
treated with corticosteroids (0.51 mg/kg/day) in addition to tamoxifen
(10–20 mg daily) and four with only total parenteral nutrition. Only one
patient received corticosteroids (1 mg/kg/day) combined with elective
surgical intervention, adhesiolysis. Of the 8 patients diagnosed with EPS,
4 died with an overall mortality rate of 50%.
In this retrospective analysis, we conﬁrmed that EPS is rare but a serious
life threatening complication in patients on long-term PD. To reduce the
incidence and mortality of EPS, careful monitoring and early diagnosis may
be needed.
http://dx.doi.org/10.1016/j.krcp.2012.04.403
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THE INFLUENCE OF LEAN BODY MASS IN PD PATIENTS
Kuan-Yu Hung, Yu-Chung Lien, Hong-Yen Wu, Chih-Kang Chiang, Jenq-
Wen Huang
National Taiwan University Hospital, Taipei, Taiwan
Nutrition is one of the important issues and edema will overestimate the
real body weight among dialysis patients. Lean body mass might reﬂect the
real nutrition status. Creatinine is the product of muscle metabolism,
creatinine generation can reﬂect the lean body mass (LBM). In peritoneal
dialysis (PD) patients, creatinine generation could be evaluated by routine
clearance measurement. This study will investigate the relationship among
LBM, patient survival and PD technique therapy. Between 2002 and 2003, a
total 115 patients who underwent PD for more than 3 months were
enrolled in this study. Follow up ended in Dec. 2011. These patients were
categorized into two groups according the median value of lean body mass
to body weight (LBM/BW %) evaluated at ﬁrst month. Age, sex, serum
creatinine, albumin, and normalized protein catabolic rate (nPCR) were the
independent determinants for LBM/BW%. The patient survival (68 vs 94
months ) and technique survival (55 vs 65 months) were longer in the
higher LBM/BW%. Besides, peritonitis incidence, hospitalization episodes
and hospitalization stay duration were lower in the higher LBM/BW%
groups. The LBM/BW% is also the independent determinant for technique
and patient survival after adjustment of age, diabetes, sex.
In conclusion, initial LBM/BM% can predict PD patients and technique
survival. Since the LBM/BW% is easily obtained in the routine PD clearance
measurement and can reﬂect the real nutrition status, this parameter could
be used extendedly to predict PD outcomes.
http://dx.doi.org/10.1016/j.krcp.2012.04.404
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ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IS INCREASED
FOLLOWING MISSED DIALYSIS SESSIONS
T. Christopher Bond 1, Steven Wang 1, Jaime Rubin 1, Alex Yang 2
1
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2
Affymax, Palo Alto, CA, USA
Missed dialysis sessions can have a cascading effect on patient clinical
outcomes. In addition to missing the dialysis itself, patients fail to receive
medications—such as ESAs—that are dosed at each session. This analysis
assessed ESA dose changes following missed session episodes in order to
evaluate ‘‘catch-up dosing.’’
In a retrospective analysis, we assessed missed session and epoetin alfa
(EPO) utilization data in 2010 from adult (Z 18 yrs old), hemodialysis (HD)
patients. Consecutive misses were considered part of a missed session
‘‘episode.’’ All misses were included (even if patient was hospitalized).
Differences in EPO utilization in the periods 14 days, 30 days and 31-60
days before and after missed session episodes were calculated and
stratiﬁed by length of episode, and whether additional sessions were
missed in the before/after periods. Total monthly EPO dose was also
calculated and stratiﬁed by number of missed sessions.
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